Pelthos Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $9,389 | $7,406 | $0 | $0 |
Gross Profit | 6,500 | 4,022 | ||
EBITDA | -10,786 | -14,215 | -3,230 | -1,833 |
EBIT | -12,003 | -15,357 | ||
Net Income | -21,664 | -16,238 | -3,448 | -1,967 |
Net Change In Cash | 9,389 | 7,406 | 0 | 0 |
Free Cash Flow | -6,351 | -15,258 | -447 | -632 |
Cash | 18,023 | 14,253 | 59 | 131 |
Basic Shares | 3,154 | 640 | 640 | 612 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $16,795 | $0 | $0 | $0 |
Gross Profit | 10,522 | 0 | ||
EBITDA | -30,071 | -7,168 | -6,862 | -2,318 |
EBIT | -32,430 | |||
Net Income | -43,319 | -7,955 | -7,380 | -2,458 |
Net Change In Cash | 16,795 | 0 | 0 | 0 |
Free Cash Flow | -22,689 | -5,792 | -981 | -1,567 |
Cash | 18,023 | 513 | 96 | 55 |
Basic Shares | 1,880 | 587 | 576 | 576 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$6.86 |
2025-09-30 | -$5.30 |
2025-06-30 | -$5.38 |
2025-03-31 | -$3.21 |